[HTML][HTML] Remdesivir for the treatment of Covid-19
…, WR Short, G Touloumi, DC Lye… - … England Journal of …, 2020 - Mass Medical Soc
Background Although several therapeutic agents have been evaluated for the treatment of
coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …
coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …
Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore
Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in
Wuhan, China, in December 2019 and has spread globally with sustained human-to-human …
Wuhan, China, in December 2019 and has spread globally with sustained human-to-human …
Remdesivir for the treatment of Covid-19—preliminary report
…, WR Short, G Touloumi, DC Lye… - … England Journal of …, 2020 - discovery.ucl.ac.uk
BACKGROUND: Although several therapeutic agents have been evaluated for the treatment
of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …
of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Neutralizing antibodies have become an important tool in treating infectious diseases.
Recently, two separate approaches yielded successful antibody treatments for Ebola—one from …
Recently, two separate approaches yielded successful antibody treatments for Ebola—one from …
[HTML][HTML] Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
Objectives Highly effective vaccines against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) have been developed but variants of concerns are worrisome, especially B.…
2 (SARS-CoV-2) have been developed but variants of concerns are worrisome, especially B.…
[HTML][HTML] Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with
a 382-nucleotide deletion (∆382) in the open reading frame 8 (ORF8) region of the genome …
a 382-nucleotide deletion (∆382) in the open reading frame 8 (ORF8) region of the genome …
[HTML][HTML] Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B. 1.1. 7 (Alpha), B. 1.315 (Beta), and B. 1.617. 2 …
Background: The impact of SARS-CoV-2 variants of concern (VOCs) on disease severity is
unclear. In this retrospective cohort study, we compared outcomes of patients infected with B. …
unclear. In this retrospective cohort study, we compared outcomes of patients infected with B. …
Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread rapidly across
the globe to cause a pandemic. Although it is known to be transmitted via droplets, …
the globe to cause a pandemic. Although it is known to be transmitted via droplets, …
[HTML][HTML] Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
Background Studies have found different waning rates of neutralising antibodies compared
with binding antibodies against SARS-CoV-2. The impact of neutralising antibody waning …
with binding antibodies against SARS-CoV-2. The impact of neutralising antibody waning …
Clinical and virological features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern: a retrospective cohort study comparing B. 1.1 …
Background The impact of SARS-CoV-2 variants of concern (VOCs) on disease severity is
unclear. In this retrospective study, we compared the outcomes of patients infected with B.1.1.7…
unclear. In this retrospective study, we compared the outcomes of patients infected with B.1.1.7…
